Nitazoxanide for infection of belly fluid in cirrhosis
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial is testing whether an antiparasitic medicine called nitazoxanide can help treat a type of infection in the belly fluid that happens in people with liver cirrhosis. If you have cirrhosis and this infection, joining might give you access to a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to have liver cirrhosis (scarring of the liver) that has been confirmed by your doctor.
- You must have fluid in your belly (ascites), and that fluid must show signs of an infection (high white blood cell count).
- Your infection should not be caused by other issues like recent surgery, cancer, or severe kidney problems.
- You should not be pregnant or breastfeeding, and you must not be allergic to the study drug.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding N-acetylcysteine (an antioxidant supplement) to standard treatment helps fight an infection in the belly fluid of people with liver cirrhosis. It aims to improve recovery and reduce complications.
This trial tests whether a medication called nitazoxanide can help people with liver cirrhosis who have just had a sudden health decline. The goal is to prevent further liver failure and improve recovery.
This study tests a medicine called nitazoxanide to treat cryptosporidium, a germ that can cause diarrhea in children. If your child tests positive for this germ, the treatment may help clear the infection.
This study tests whether adding nitazoxanide, an anti-parasitic medicine, to your current ulcerative colitis treatment helps reduce inflammation and symptoms. It may offer an extra option for people with mild-to-moderate disease.
This Phase 3 trial tests whether nitazoxanide can help stop hepatic encephalopathy (a “liver-to-brain” confusion problem) from coming back. It’s for adults with cirrhosis who have had at least one past episode, aiming to improve safety and prevent recurrence.
This trial tests if a medication called nitazoxanide can help people with mild to moderate ulcerative colitis (UC). It may be a treatment option for those not already on strong UC medications.
Hear when a new SBP - Spontaneous Bacterial Peritonitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.